The table contains 12 products whose active ingredient are classified under the same pharmacologic class PCSK9 Inhibitors [MoA].
|
NDC |
Proprietary Name |
Non-Proprietary Name |
Dosage Form |
Route Name |
Company Name |
Status |
| 0024-5901 | Praluent | Non-Proprietary Name: Alirocumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE |
| 0024-5902 | Praluent | Non-Proprietary Name: Alirocumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE |
| 0024-5903 | Praluent | Non-Proprietary Name: Alirocumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE |
| 0024-5904 | Praluent | Non-Proprietary Name: Alirocumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE |
| 55513-750 | Repatha | Non-Proprietary Name: Evolocumab | Injection, Solution | Subcutaneous | Amgen Inc | ACTIVE |
| 55513-760 | Repatha | Non-Proprietary Name: Evolocumab | Injection, Solution | Subcutaneous | Amgen Inc | ACTIVE |
| 61755-020 | Praluent | Non-Proprietary Name: Alirocumab | Injection, Solution | Subcutaneous | Regeneron Pharmaceuticals, Inc. | ACTIVE |
| 61755-021 | Praluent | Non-Proprietary Name: Alirocumab | Injection, Solution | Subcutaneous | Regeneron Pharmaceuticals, Inc. | ACTIVE |
| 72511-750 | Repatha | Non-Proprietary Name: Evolocumab | Injection, Solution | Subcutaneous | Amgen Usa Inc. | ACTIVE |
| 72511-760 | Repatha | Non-Proprietary Name: Evolocumab | Injection, Solution | Subcutaneous | Amgen Usa Inc. | ACTIVE |
| 72733-5901 | Praluent | Non-Proprietary Name: Alirocumab | Injection, Solution | Subcutaneous | Sanofi Us Corporation | ACTIVE |
| 72733-5902 | Praluent | Non-Proprietary Name: Alirocumab | Injection, Solution | Subcutaneous | Sanofi Us Corporation | ACTIVE |